Current advances in the treatment of medial and lateral epicondylitis
- PMID: 29657450
- PMCID: PMC5895908
- DOI: 10.1016/j.jor.2018.01.040
Current advances in the treatment of medial and lateral epicondylitis
Abstract
Despite advances elucidating the causes of lateral and medial epicondylitis, the standard of care remains conservative management with NSAIDs, physical therapy, bracing, and rest. Scar tissue formation provoked by conservative management creates a tendon lacking the biomechanical properties and mechanical strength of normal tendon. The following review analyzes novel therapies to regenerate tendon and regain function in patients with epicondylitis. These treatments include PRP injection, BMAC, collagen-producing cell injection, and stem cell treatments. While these treatments are in early stages of investigation, they may warrant further consideration based on prospects of pain alleviation, function enhancement, and improved healing.
Keywords: Lateral/medial epicondylitis; Stem cell therapy; Tendonopathy; Tenocyte therapy.
References
-
- Shiri R., Viikari-Juntura E., Varonen H., Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164(11):1065–1074. - PubMed
-
- Ikpe S., Lesniak B. Biologics and Cell-Based Treatments for Upper Extremity Injuries. Oper Tech Orthop. 2016;26(3):177–181.
-
- Connell D., Datir A., Alyas F., Curtis M. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med. 2009;43(4):293–298. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
